Obesity treatments are evolving, and one pharmaceutical giant is making headlines with a tiny but mighty pill. Eli Lilly, a company with over 140 years of history in innovation, is stepping into uncharted territory with its oral GLP-1 weight-loss drug, orforglipron—a potential game-changer in a market dominated by injectables.

Join Dan Koh and Emaad Akhtar as they tear down the story behind the company, the science behind orforglipron, and what it means for investors and the future of healthcare.

Obesity treatments are evolving, and one pharmaceutical giant is making headlines with a tiny but mighty pill. Eli Lilly, a company with over 140 years of history in innovation, is stepping into uncharted territory with its oral GLP-1 weight-loss drug, orforglipron&mdash;a potential game-changer in a market dominated by injectables.
Join Dan Koh and Emaad Akhtar as they tear down the story behind the company, the science behind orforglipron, and what it means for investors and the future of healthcare.

Insightful discussions on the latest market events and the top companies to watch.

Get a head start to your work day with Ryan Huang, Emaad Akhtar and Audrey Siek from 6am to 9am. 

Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Get a head start to your work day with Ryan Huang, Emaad Akhtar and Audrey Siek from 6am to 9am. 
Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek

Get a head start on your workday with Ryan Huang, Emaad Akhtar and Audrey Siek from 6 am to 9 am. 

Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Get a head start on your workday with Ryan Huang, Emaad Akhtar and Audrey Siek from 6 am to 9 am. 
Listen to insightful discussions on the stories and issues that matter the most to you and be apprised of the markets and the companies to watch.

Advertisement